Capital World Investors Bluebird Bio, Inc. Transaction History

Capital World Investors

$625 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $51.9 Million - $106 Million	-3,127,163 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$27.5 - $37.92 $9.47 Million - $13.1 Million	-344,380 Reduced 9.92%	3,127,163 $135 Million
Q3 2020 Nov 13, 2020	BUY	$34.44 - $43.75 $26,139 - $33,206	759 Added 0.02%	3,471,543 $187 Million
Q2 2020 Aug 14, 2020	SELL	$27.12 - $45.97 $23.6 Million - $40 Million	-870,154 Reduced 20.05%	3,470,784 $212 Million
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $24.2 Million - $58.8 Million	-926,052 Reduced 17.58%	4,340,938 $200 Million
Q4 2019 Feb 18, 2020	BUY	$46.96 - $61.67 $3.15 Million - $4.14 Million	67,060 Added 1.29%	5,266,990 $462 Million
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $47 Million - $73.6 Million	790,837 Added 17.94%	5,199,930 $477 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $29.1 Million - $40.4 Million	384,310 Added 9.55%	4,409,093 $561 Million
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $20.1 Million - $32.5 Million	312,002 Added 8.4%	4,024,783 $633 Million
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $17 Million - $26.8 Million	287,094 Added 8.38%	3,712,781 $368 Million
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $82.8 Million - $109 Million	931,932 Added 37.37%	3,425,687 $500 Million
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $39.2 Million - $50.1 Million	393,000 Added 18.71%	2,493,755 $391 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $35.2 Million - $50.3 Million	333,000 Added 18.84%	2,100,755 $359 Million
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $51.5 Million - $82.9 Million	634,000 Added 55.92%	1,767,755 $315 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $65.5 Million - $104 Million	1,133,755	1,133,755 $156 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.67 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.64 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.63 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.34 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account